FDA clears Novavax to resume trials of Covid-19 and flu combo vaccine
The FDA agreed for Novavax to continue trials of its vaccine combo after addressing a serious adverse event that paused trials.
The FDA agreed for Novavax to continue trials of its vaccine combo after addressing a serious adverse event that paused trials.
What's Your Reaction?
